159 related articles for article (PubMed ID: 27621317)
1. 3'-NADP and 3'-NAADP, Two Metabolites Formed by the Bacterial Type III Effector AvrRxo1.
Schuebel F; Rocker A; Edelmann D; Schessner J; Brieke C; Meinhart A
J Biol Chem; 2016 Oct; 291(44):22868-22880. PubMed ID: 27621317
[TBL] [Abstract][Full Text] [Related]
2. The effector AvrRxo1 phosphorylates NAD in planta.
Shidore T; Broeckling CD; Kirkwood JS; Long JJ; Miao J; Zhao B; Leach JE; Triplett LR
PLoS Pathog; 2017 Jun; 13(6):e1006442. PubMed ID: 28628666
[TBL] [Abstract][Full Text] [Related]
3. Chemo-enzymatic synthesis of adenine substituted nicotinic acid adenine dinucleotide phosphate (NAADP) analogs.
Su P; Bretz JD; Gunaratne GS; Marchant JS; Walseth TF; Slama JT
Bioorg Med Chem; 2021 Jan; 30():115901. PubMed ID: 33321420
[TBL] [Abstract][Full Text] [Related]
4. AvrRxo1 Is a Bifunctional Type III Secreted Effector and Toxin-Antitoxin System Component with Homologs in Diverse Environmental Contexts.
Triplett LR; Shidore T; Long J; Miao J; Wu S; Han Q; Zhou C; Ishihara H; Li J; Zhao B; Leach JE
PLoS One; 2016; 11(7):e0158856. PubMed ID: 27391081
[TBL] [Abstract][Full Text] [Related]
5. Crystal Structure of Xanthomonas AvrRxo1-ORF1, a Type III Effector with a Polynucleotide Kinase Domain, and Its Interactor AvrRxo1-ORF2.
Han Q; Zhou C; Wu S; Liu Y; Triplett L; Miao J; Tokuhisa J; Deblais L; Robinson H; Leach JE; Li J; Zhao B
Structure; 2015 Oct; 23(10):1900-1909. PubMed ID: 26344722
[TBL] [Abstract][Full Text] [Related]
6. A novel cycling assay for nicotinic acid-adenine dinucleotide phosphate with nanomolar sensitivity.
Graeff R; Lee HC
Biochem J; 2002 Oct; 367(Pt 1):163-8. PubMed ID: 12117413
[TBL] [Abstract][Full Text] [Related]
7. Nicotinic Acid Adenine Dinucleotide Phosphate Plays a Critical Role in Naive and Effector Murine T Cells but Not Natural Regulatory T Cells.
Ali RA; Camick C; Wiles K; Walseth TF; Slama JT; Bhattacharya S; Giovannucci DR; Wall KA
J Biol Chem; 2016 Feb; 291(9):4503-22. PubMed ID: 26728458
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of the novel Ca2+-mobilizing messenger nicotinic acid-adenine dinucleotide phosphate via a 2'-specific Ca2+-dependent phosphatase.
Berridge G; Cramer R; Galione A; Patel S
Biochem J; 2002 Jul; 365(Pt 1):295-301. PubMed ID: 11936953
[TBL] [Abstract][Full Text] [Related]
9. Integration of nicotinic acid adenine dinucleotide phosphate (NAADP)-dependent calcium signalling.
Guse AH; Diercks BP
J Physiol; 2018 Jul; 596(14):2735-2743. PubMed ID: 29635794
[TBL] [Abstract][Full Text] [Related]
10. To be or not to be ... nicotinic acid adenine dinucleotide phosphate (NAADP): a new intracellular second messenger?
Chini EN
Biol Res; 2004; 37(4):559-63. PubMed ID: 15709682
[TBL] [Abstract][Full Text] [Related]
11. Production and characterization of reduced NAADP (nicotinic acid-adenine dinucleotide phosphate).
Billington RA; Thuring JW; Conway SJ; Packman L; Holmes AB; Genazzani AA
Biochem J; 2004 Feb; 378(Pt 1):275-80. PubMed ID: 14606955
[TBL] [Abstract][Full Text] [Related]
12. An enzymatic cycling assay for nicotinic acid adenine dinucleotide phosphate using NAD synthetase.
Yamaguchi F; Ohshima T; Sakuraba H
Anal Biochem; 2007 May; 364(2):97-103. PubMed ID: 17395143
[TBL] [Abstract][Full Text] [Related]
13. Domain dissection of AvrRxo1 for suppressor, avirulence and cytotoxicity functions.
Liu H; Chang Q; Feng W; Zhang B; Wu T; Li N; Yao F; Ding X; Chu Z
PLoS One; 2014; 9(12):e113875. PubMed ID: 25437277
[TBL] [Abstract][Full Text] [Related]
14. Nicotinic acid-adenine dinucleotide phosphate activates the skeletal muscle ryanodine receptor.
Hohenegger M; Suko J; Gscheidlinger R; Drobny H; Zidar A
Biochem J; 2002 Oct; 367(Pt 2):423-31. PubMed ID: 12102654
[TBL] [Abstract][Full Text] [Related]
15. Calcium signalling by nicotinic acid adenine dinucleotide phosphate (NAADP).
Yamasaki M; Churchill GC; Galione A
FEBS J; 2005 Sep; 272(18):4598-606. PubMed ID: 16156782
[TBL] [Abstract][Full Text] [Related]
16. Ca2+ signalling: a new route to NAADP.
Rutter GA; Bellomo EA
Biochem J; 2008 Apr; 411(1):e1-3. PubMed ID: 18333834
[TBL] [Abstract][Full Text] [Related]
17. Nicotinic Acid Adenine Dinucleotide Phosphate Analogues Substituted on the Nicotinic Acid and Adenine Ribosides. Effects on ReceptorMediated Ca²⁺ Release.
Trabbic CJ; Zhang F; Walseth TF; Slama JT
J Med Chem; 2015 Apr; 58(8):3593-610. PubMed ID: 25826221
[TBL] [Abstract][Full Text] [Related]
18. Chemical synthesis of the novel Ca2+ messenger NAADP.
Dowden J; Brown RS; Moreau C; Galione A; Potter BV
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):513-8. PubMed ID: 16247981
[TBL] [Abstract][Full Text] [Related]
19. CD38: a NAADP degrading enzyme.
Schmid F; Bruhn S; Weber K; Mittrücker HW; Guse AH
FEBS Lett; 2011 Nov; 585(22):3544-8. PubMed ID: 22020217
[TBL] [Abstract][Full Text] [Related]
20. NAADP signaling revisited.
Guse AH; Ernst IM; Fliegert R
Curr Top Med Chem; 2013; 13(23):2978-90. PubMed ID: 24171770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
